Objective: To describe maternal and perinatal morbidity and mortality associated with uterine rupture (UR) among women with prior cesarean/s, singleton term pregnancies and a trial of labor after cesarean (TOLAC).
Introduction
The consequences of uterine rupture (UR) before, during or after birth can range from inconsequential to catastrophic for mother and/or baby. Among women with a previous cesarean who undergo a trial of labor after a cesarean (TOLAC), UR is still a relatively rare event (0.3 to 0.7%).
1,2 A recent review of vaginal birth after cesarean (VBAC) has noted a paucity of evidence on identifying those at risk for adverse outcomes. 1 As the overall (31.1% in 2006) and primary (23.5%) cesarean rates continue to rise, 3, 4 putting more women at risk of UR, identification of the clinical and demographic factors associated with severe outcomes is needed by providers to counsel patients appropriately.
Although immediate maternal outcomes from UR have been reported in many studies, fewer studies have followed infant outcomes beyond reporting perinatal death rates. 1 Most of these studies have been from single institutions, typically academic medical institutions, with the exception of the multicenter prospective cohort study reported by Landon et al. 2 conducted at 19 academic medical centers. The only two previous populationbased studies using clinical databases to investigate maternal and perinatal outcomes following UR were conducted outside the United States. 5, 6 The Massachusetts Uterine Rupture Study was undertaken to identify all true cases of UR between 1990 and 1998, regardless of the history of previous cesarean or gestational age, using a combination of linked administrative data and information from abstracted medical records. 7 This paper focuses on the subgroup of women identified in the study who had a singleton, term pregnancy and who attempted a VBAC and experienced a UR. During the study period, the rate of VBAC in Massachusetts reached a peak of 34% in 1996, 6 percentage points higher than the national rate, making Massachusetts an appropriate setting in which to study outcomes among women with a trial of labor. We studied UR cases to assess the severity of maternal and fetal/neonatal outcomes among this population, and to identify possible demographic, obstetric and labor management risk factors associated with a severe outcome related to the UR.
Methods
Suspected cases of UR were identified from hospital discharge data for all Massachusetts deliveries between 1990 and 1998, using one of three International Classification of Diseases-9 diagnosis codes (665.0/1, 664.1) for UR. 7 Suspected case hospital discharge files were linked with birth and fetal death certificates, and maternal and infant death files.
A limited medical record containing the face sheet, discharge summary and delivery or surgical reports were obtained for 97.5% of the 1488 suspect cases. Each record was reviewed by two clinicians (from a team of three obstetricians and one nursemidwife) to confirm a UR. A total of 573 cases met the definition of any unintentional disruption of the complete uterine wall including the visceral peritoneum in a pregnant woman, regardless of size, degree of severity or location. 7 Of the 573 cases, the complete medical record was obtained for 566 women (see Figure 1 ). Trained obstetrical nurses abstracted data from the charts of mothers using a structured abstraction protocol. A 10% random sample of independently abstracted charts showed 99% agreement between abstractors on variables used in this analysis.
For this study, subjects had to meet the four principal study criteria: (1) singleton pregnancy; (2) delivered between 37 and 42 weeks of gestation; (3) previous cesarean; and (4) underwent a trial of labor. 'Trial of labor' was defined using the Maryland Quality Indicator Project definition: 'the attempt to establish a pattern of uterine contractions in a gravid woman with a history of a previous cesarean'. 8 Data on subjects were drawn from four sources: (1) birth certificate or fetal death record linked to the associated electronic hospital discharge records that included a unique identification number, which in most cases was an encrypted social security number; (2) the mother's hospital delivery record; (3) her prenatal record contained in the hospital delivery record by law; and (4) the medical record of infants who died before discharge and/or had a 5-min Apgar score of <7. Longitudinally linked hospital discharge records were used to assess both maternal and neonatal morbidity, and linkage to mortality records identified mothers and infants who died within 1 year of the birth. The unique identification number allowed linking to any other hospital discharge data that identified if any women were re-admitted to any Massachusetts hospital within 6 weeks of the birth. All infant records from the birth hospital and hospital to which an infant may have been transferred were reviewed until the baby was discharged home from either the birth or transfer hospital.
The Massachusetts Department of Public Health Human Research Review Committee approved this study.
Outcome definition
For mothers, a 'severe' outcome was defined as having a hysterectomy, need for mechanical ventilation or a blood transfusion or a maternal death. Other potential variables for maternal severity were examined: admission to an intensive care unit, development of adult respiratory distress syndrome and organ failure; however, every woman experiencing these events also had a blood transfusion. 'Severe' infant outcomes included perinatal death (fetal or neonatal), a 5-min Apgar score of <4 or a 5-min Apgar score of 4 to 6 requiring assisted ventilation.
Outcomes were categorized based on relatedness to the rupture, with and without comorbidities that may have contributed to the poor outcome. An obstetrician and nurse-midwife independently rated each hysterectomy (which included the one maternal death in the study). A hysterectomy was rated as related to the rupture if no obvious comorbidity or other agent for bleeding was identified. A hysterectomy was rated as unrelated to the rupture if there was a placenta percreta or increta, or if bleeding was from the placental site or another site clearly unrelated to the rupture, such that a hysterectomy would have been required regardless of the rupture.
Two neonatologists independently reviewed the infant records to determine relatedness of perinatal outcomes to the rupture. A death or low Apgar score was related to the rupture if no other Figure 1 Massachusetts uterine rupture study population. CS, cesarean section.
Severe outcomes from uterine rupture MK Barger et al condition was noted that could be responsible for the poor outcome. Comorbidities included other conditions that could have contributed to the infant's condition. An outcome was unrelated to the rupture if another condition, for example congenital anomaly, was present and the rupture was an incidental finding. Examples of reasons to classify a rupture as an 'incidental finding' included fetal demise before labor, coupled with evidence that the UR occurred late in labor, and the death of an infant with a lethal congenital anomaly at a time remote from the UR event. Hypoxic ischemic encephalopathy was identified when the Sarnat score was greater than stage 1. 9 In addition, the neonatologists independently rated the prognosis of infants on discharge home as either poor/ fair or good based on the infant's hospital course. Maternal or fetal/infant mortality or severe morbidity rated as related to the UR was defined as a 'severe' UR.
Variables of interest
Maternal demographic characteristics were obtained from the birth certificate or hospital record if missing. Hospitals at which women delivered were categorized according to the Massachusetts Department of Public Health perinatal regulations, which are based on the ability to care for premature infants. 10 For the purposes of this paper, descriptive terms were chosen as labels for these categories. 'Small community' hospitals had lower delivery volume and no nurseries to care for infants <34 weeks. 'Larger community' hospitals have a larger delivery volume and units that can care for infants of >31 weeks of gestation. 'Tertiary Care' hospitals have neonatal intensive care units prepared to care for any infant. Maternal reproductive history and medical conditions were abstracted from the medical record.
Labor management variables obtained from the medical record included whether labor was induced or spontaneous, and the use of cervical ripening agents and oxytocin. Labor induction with oxytocin was differentiated from its use for labor augmentation. The maximum dose of oxytocin was recorded in milliunits per min, and the duration of use in continuous hours of use. If oxytocin was used for <30 min, it was recorded as 0 h, and if it was discontinued for >2 h, the duration was defined as the last period of continuous use.
Abstracted data included any morbidities encountered during the hospital stay such as the extent of rupture, amount of blood loss and any associated use of blood and blood products and intensive care measures for both mother and infant.
Mean values of continuous variables were compared using t-tests. Variables were also categorized based on the distribution of the data, and analyzed as categorical variables. Univariate analysis was done to assess the relation between variables and severe UR. Stratified analyses were conducted to assess confounding. If a variable associated with severe rupture was also associated with the exposures and it changed the risk estimate by >10% after adjustment, it was considered a confounder and was included in the final adjusted model. No variables met this definition. Therefore, unadjusted risks and 95% confidence intervals (95% CIs) were calculated using log-binomial multivariable regression to determine association between categorical variables and severe UR. The statistical model was fit using PROC GENMOD with binomial errors and a log-link function using SAS, version 9.1 (SAS Institute, Cary, NC, USA).
Results
There were 461 women identified with a 'true' UR at term with a singleton pregnancy of whom 347 underwent a TOL. Five women were re-admitted after discharge, 3 of them were women who had a TOL and whose re-admission was related to a severe outcome. Table 1 presents the number and types of maternal and perinatal severe morbidities for the women who underwent a trial of labors. Of these pregnancies, 25% involved a severe outcome. In comparison among 114 women without a TOLAC and a UR, 6.1% (N ¼ 7) had a severe outcome, 4 with severe maternal morbidity and 5 with perinatal morbidity or perinatal death.
Among those undergoing a TOLAC, there were 49 (14%) severe maternal outcomes and 49 (14%) severe perinatal outcomes, among which 12 had both a severe maternal and perinatal Umbilical artery blood pH documented in 30 infants. Both mother and infant had a severe outcome for 12 deliveries among those with a trial of labor and 3 of those without a trial of labor.
Severe outcomes from uterine rupture MK Barger et al outcome (Table 1) . Among the TOLAC group who experienced a severe maternal outcome, including the one maternal death, some had multiple severe outcomes; that is, the same woman might be counted in more than one category in Table 1 . Of the 20 hysterectomies related to UR, 4 had comorbidities thought to contribute to the hysterectomy, for example, presence of a low-lying placenta or possible damage to the uterus from instruments. There were two hysterectomies that were unrelated to UR. All but three women having hysterectomies required a blood transfusion. There were 18 women whose only morbidity was blood transfusion, and of these, half required other blood component therapy or volume expanders.
Of the 49 (14%) with a severe perinatal outcome, 2 infants had a contributing comorbidity. Of these infants, 14 (31% of those with a severe outcome) required transfer from their birth hospital to another hospital. There were 10 perinatal deaths (5 fetal and 5 neonatal); this does not include 3 deaths assessed to be unrelated to the UR, 1 fetal demise before labor and 2 from congenital anomalies remote from time of UR. Of the 22 infants who had 5-min Apgar scores of 4 to 6 and required mechanical ventilation, 6 (27%) were extubated and in good condition within 1 day of birth. The median cord pH of infants born alive was 6.83 (range of 6.22 to 7.29), and slightly more than one-quarter of infants in whom umbilical artery blood pH was measured had a pH of <7.0. A similar percent was diagnosed with hypoxic-ischemic encephalopathy or seizures during their hospital stay. Overall, slightly over half (N ¼ 25) of infants with a severe outcome were discharged home with a good prognosis. This represents 64.1% of the infants born alive.
The obstetrical histories of women with and without severe outcomes were also generally similar, although a nonsignificantly larger percent of women without a severe outcome had a parity of X3 ( Table 2 ). The distributions of any vaginal birth, previous vaginal births, VBACs and previous cesareans were similar between the two groups.
All women in the study had one or two previous cesareans, with the exception of one woman who had three. Among those with documented scars (92%), all women except three had low transverse incisions. Of the three women, two were low vertical and one was classical. Only one woman had other uterine surgery.
Data comparing those with and without a severe UR on the presence of symptoms, stage of labor and method of delivery are also presented in Table 2 . Of note, 15% of women who experienced a severe outcome did not have any of symptoms (that is, bleeding, pain or fetal distress) that would meet the definition of a symptomatic UR. Over half (55%) of the women delivering vaginally experienced a severe outcome compared with 21% of those delivering by cesarean. This may be because of underreporting of inconsequential URs among women delivering vaginally. Women who deliver by VBAC with no sequelae generally do not have their uterus explored for a UR and, therefore, more minor ruptures will be discovered among those with a cesarean. In all, 86% of the severe outcomes among women having a VBAC were due to maternal bleeding. The placenta was manually removed in 37% of these women, compared with 25% manual removals in the non-severe VBAC group (P ¼ 0.42). Abbreviations: UR, uterine rupture; VBAC, vaginal birth after cesarean.
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Women experiencing a severe UR were more likely to have their infant completely extruded from the uterus, and their rupture was more likely to extend into surrounding structures (P<0.0001).
Associations between maternal demographic and obstetric risk factors and severe UR outcome were examined. Maternal age of X35 years was associated with a 47% increased risk of a severe UR (see Table 3 ). Parity (Table 3) , gravidity, abortion, race/ethnicity and payer status were not associated with the study outcome (data not shown in Table 3 ). Women with severe outcomes had a mean age 1.5 years older, 32.9 (s.d. 4.2), than those with a UR but not a severe outcome, 31.4 (s.d. 4.7). The proportion of women with comorbid medical conditions was the same in those with (16%) and without (15%) a severe outcome.
Women with severe outcomes had a mean interdelivery interval of 35 months (95% CI: 24.9, 40.8) compared with a mean of 40.4 months (95% CI: 36.3, 44.4) for women who did not. The median and range of intervals was 27 (range of 12 to 180) for those with a severe outcome and 31 (range 10 to 223) months for those without (data not shown). Interdelivery intervals of p18 months increased the risk of severe UR by 56%.
Women in this study delivered in a variety of hospitals, from smaller community hospitals to academic medical centers. Whether a woman experiencing a UR had a severe outcome was unrelated to the type of hospital setting in which she delivered. Although women with a UR and with diabetes, pregnancy hypertensive disorders or other chronic conditions were more likely to deliver at a tertiary center (P ¼ 0.003), such a medical history was not related to having a severe outcome (P ¼ 0.83) Adjusting for medical history did not change the relative risk (RR) estimate associated with the type of hospital.
Use of medication for either induction or augmentation of labor was very common, with only 73 of the 347 women (21%) having completely spontaneous labors. A total of 43% of women had their labors induced with either prostaglandins alone (N ¼ 11) and/or oxytocin, with another 36% receiving oxytocin for the augmentation of labor. Although the risk for severe UR associated with induction or augmentation was B50% higher, these findings were not statistically significant. The number of women exposed solely to prostaglandins was too small to provide precise RRs, but analysis of oxytocin alone for induction and augmentation had nearly the same results as those for type of labor in Table 3 . On examining the hours and dose of oxytocin, only one finding was significantFwomen had a 67% increased risk of a severe UR in the first 4 h of oxytocin infusion. Investigation of possible identifying demographic or obstetrical history risk factors in this group of women rupturing early only revealed that the presence of a previous VBAC was strongly protective (P ¼ 0.03). When oxytocin used for induction versus augmentation was examined, this finding was only significant among those induced with oxytocin. Among those induced, compared with women with >8 h of exposure, the risk of a severe outcome was 2.5 times as much for oxytocin used in the first 4 h (unadjusted RR ¼ 2.56; 95% CI: 1.39, 4.70). This risk persisted when those exposed to prostaglandins were removed (unadjusted RR ¼ 2.29; 95% CI: 0.12, 4.69).
Discussion
This study represents the largest population-based data set to date of validated URs occurring in a wide range of hospitals from small community hospitals to tertiary centers. It is also the only study to follow women for re-hospitalization through 6 weeks postpartum and infants for documented morbidities until discharged home. This permitted us to identify 5 women re-admitted and 3 infant deaths beyond 28 days. The medical record review employed in this study made it possible to confirm whether a woman met a specific definition of UR, to accurately classify her exposures and to distinguish women intending a trial of labor from those intending a repeat cesarean. Reviewing infant charts also allowed determination of whether infant outcomes were directly related to the UR or to some other condition, and the fact that we were able to follow infants even if transferred to another hospital until discharged home allowed a longer period of time to assess possible prognosis. The fact that we did not find a difference in severe outcome by hospital type is reassuring that hospitals in Massachusetts are well prepared for an obstetrical emergency like UR. However, these findings may not be generalizable to geographically larger states that do not have as good a dispersion of tertiary care hospitals for rapid transfer or perinatal licensure regulations that require close obstetrical and neonatal interaction between tertiary centers and community hospitals. 10 The definition for severe maternal outcome of this study reflects the management-based group diagnoses for 'near-miss' mortality suggested by the World Health Organization. 11 Additionally, the Massachusetts Maternal Mortality and Morbidity Review Committee, for counseling purposes, wanted a more conservative estimate of severity for mother and infant that would reflect the range of less than ideal outcomes caused by UR. Maternal morbidity in this study is similar to that of two other population-based studies that detailed maternal morbidity from UR, one from Nova Scotia, which identified 18 'complete' ruptures (using a definition similar to the one used here), 5 and one from the Netherlands, which had 91 symptomatic ruptures among women with a trial of labor. 6 Hysterectomy rates in those studies were similar (5.6% and 4.1%, respectively) to the 5.7% rate found in the present study. The rate of maternal transfusion in this study (13%) was lower than those reported in Nova Scotia (44%) and the Netherlands (19%). These differences may be because of different transfusion guidelines in these countries.
Three previous studies have detailed perinatal outcomes from UR: the two studies just mentioned, and a US multicenter prospective cohort study that identified 114 URs in term pregnancies. 2 The present study had 10 perinatal deaths, yielding a perinatal mortality rate of 2.9% compared with the perinatal mortality rate among women without TOLAC of 2.6%. This rate is lower than the 11% perinatal mortality rate found in the nonAmerican studies, but is slightly higher than the 1.8% rate found in the US study. The two non-American studies included preterm infants, which may account for some of the differences. The one percentage point higher rate found in our study compared with the multicenter study might be explained by the fact that infants in the present study were followed beyond 28 days. The present study's rate of hypoxic-ischemic encephalopathy and/or seizures was 2.9%, half that found in the multicenter US study. The rate of umbilical cord pH <7 was 27%, similar to the multicenter study but considerably higher than the 10% rate found in the Netherlands study.
Although other studies that showed oxytocin use increased the risk of UR, 12, 13 this study did not find that oxytocin exposure increased the risk of having a severe outcome from a UR. However, severe outcomes were more likely to occur during the first 4 h of oxytocin used for induction. This could indicate that some women have weaker scars that will rupture with a lesser amount of total uterine force and these are more likely to result in larger, more sudden URs with more severe outcomes.
Maternal age of >35 years has been identified as a risk factor for UR following a TOL.
14, 15 The present study found that older women who experience a UR were somewhat more likely to have a severe outcome. In addition, several studies have identified short interdelivery intervals of <6, 18 or 24 months as risk factors for UR. [16] [17] [18] In this study, women with interdelivery intervals of p18 months had a 60% increased risk of a severe outcome related to UR. This information may provide obstetric providers with even more motivation to counsel women who have had a cesarean to postpone a subsequent pregnancy for more than 1 year.
Study limitations include reliance on hospital discharge coding for initial identification of URs. We have no way of verifying that we identified all cases of UR. Undoubtedly, many 'silent' URs were missed among women with a successful VBAC who had no complications, biasing the results toward a higher proportion of severe outcomes among women with a VBAC. Approximately onethird of the medical records were missing some elements, such as the prenatal record (most common), nursing or provider progress notes during labor or laboratory values. However, missing data were equally distributed between those with and without a severe outcome.
This study suggests that among the small percentage of women who experience a UR after a TOLAC (0.3 to 0.7%), 1,2 one in four women will experience a severe outcome for themselves or their infants. However, our data show a 6% baseline risk of a severe outcome among women not undergoing TOLAC, resulting in an actual increased risk of 19% among those with TOLAC. Assuming the more conservative 0.7% UR rate among term women with a TOLAC found in the US multicenter trial, 2 the overall risk that a trial of labor will result in a UR that causes a severe maternal or infant outcome of any kind is estimated to be <1.3 in 1000. This risk should be balanced against that of elective cesarean that, when done before 39 weeks, has some severe neonatal outcomes: respiratory distress syndrome (9/1000) or need for mechanical ventilation (4/1000) 19 and the long-term maternal risks associated with increased placental problems in subsequent pregnancies. 1 
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